Ryan S Sultan, MD

Dr. Ryan Sultan is a board-certified psychiatrist who is an expert in ADHD, psychedelics, and substance use, including cannabis.

Dr. Sultan’s research focuses on the interface of electronic databases, epidemiology, and evidence-based treatments with common psychiatric disorders. Dr. Sultan works closely with Drs. Mark Olfson, Frances Levin, and Tim Wilens as both a privately and NIH funded researcher. Dr. Sultan’s work has been published in academic journals and presented both nationally and internationally.

Dr. Sultan completed his training as a physician at Emory School of Medicine, New York-Presbyterian Weill Cornell Medical College, and the Columbia University Irving Medical Center. Dr. Sultan has been featured in Time Magazine and on NPR's Morning Edition

In addition to his work as a researcher, Dr. Sultan also is the director of the Integrative Psych in Manhattan which provides ground-breaking individualized mental health treatment for adults, youths, and families. He specializes in advanced psychotherapy and psychopharmacology for individuals with ADHD, Anxiety, and substance use disorders.

Areas of Expertise / Conditions Treated
• Adult Psychiatry
• Anxiety and Depression
• Anxiety Disorders
• Attention Deficit Hyperactivity Disorder (ADHD)
• Behavior Problems
• Bipolar Disorder
• Panic Attacks
• Parenting Issues
• Ketamine
• Psychopharmacology
• Psychotherapy

Publications:
Sultan RS, Liu SM, Hacker KA, Olfson M. Adolescents With Attention-Deficit/Hyperactivity Disorder: Adverse Behaviors and Comorbidity. J Adolesc Health. 2021 Feb;68(2):284-291. doi: 10.1016/j.jadohealth.2020.09.036. Erratum in: J Adolesc Health. 2021 May;68(5):1024. PMID: 33541601.

Sultan RS. Wang S. Crystal S. Olfson M. Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder, JAMA Network Open. 2019;2(7):e197850. doi:10.1001/jamanetworkopen.2019.7850

Sultan R.S. Correll, C.U. Zohor, J. Zalsman G. Veenstra-VanderWeele J. What's in a Name? Moving to Neuroscience-based Nomenclature in Pediatric Psychopharmacology. Journal of the American Academy of Child & Adolescent Psychiatry. 2018 Oct;57(10):719-721.doi.org/10.1016/j.jaac.2018.05.024.

Sultan R.S. Correll C. Schoenbaum M. King M. Walkup J. T. Olfson M. National Patterns of Commonly Prescribed Psychotropic Medications to Young People. J Child Adolesc Psychopharmacol. 2018 Jan 29. doi:10.1089/cap.2017.0077.

Olfson, M. Wall M. Shang-Min L. Sultan R.S. Blanco C. E-cigarette Use Among Young Adults in the U.S. Am J Prev Med. 2019 Mar 16. pii: S0749-3797(19)30024-8. doi: 10.1016/j.amepre.2018.12.004

Sultan R.S. Olfson M. Correll C. Duncan, E. Evaluating the Effect of the Changes in FDA Guidelines for Clozapine Monitoring J Clin Psychiatry. 2017 Jul 18. pii: 16m11152. doi: 10.4088/JCP.16m11152.

Sultan R, Riva-Posse P, Garlow SJ, Schwartz AC. Beneficial pre-ECT ketamine infusion in a patient with treatment-resistant depression. Psychosomatics. 2014 Jul-Aug;55(4):396-399. doi: 10.1016/j.psym.2013.12.002. Epub 2013 Dec 4.

Sultan RS, Liu SM, Hacker KA, Olfson M. Adolescents With Attention-Deficit/Hyperactivity Disorder: Adverse Behaviors and Comorbidity. J Adolesc Health. 2021 Feb;68(2):284-291. doi: 10.1016/j.jadohealth.2020.09.036. Erratum in: J Adolesc Health. 2021 May;68(5):1024. PMID: 33541601.

Research Interests
• ADHD
• Anxiety/mood disorders (panic disorder, social anxiety, phobias, generalized anxiety, depression)
• Depression, including treatment-refractory depression
• Cannabis
• Public Health
• Substance Use Disorders